PTHR1 Loss-of-Function Mutations in Familial, Nonsyndromic Primary Failure of Tooth Eruption  by Decker, Eva et al.
REPORTPTHR1 Loss-of-Function Mutations in Familial,
Nonsyndromic Primary Failure of Tooth Eruption
Eva Decker,1,2,6 Angelika Stellzig-Eisenhauer,3,6 Britta S. Fiebig,1 Christiane Rau,3 Wolfram Kress,4
Kathrin Saar,5 Franz Ru¨schendorf,5 Norbert Hubner,5 Tiemo Grimm,4 and Bernhard H.F. Weber1,*
Tooth eruption is a complex developmental process requiring coordinated navigation through alveolar bone and oral epithelium.
Primary failure of tooth eruption (PFE) is associatedwith several syndromes primarily affecting skeletal development, but it is also known
as a nonsyndromic autosomal-dominant condition. Teeth in the posterior quadrants of the upper and lower jaw are preferentially
affected and usually result in an open bite extending from anterior to posterior. In this study, we show that familial, nonsyndromic
PFE is caused by heterozygousmutations in the gene encoding the G protein-coupled receptor for parathyroid hormone and parathyroid
hormone-like hormone (PTHR1). Three distinct mutations, namely c.1050-3C > G, c.543þ1G > A, and c.463G > T, were identiﬁed in
15 affected individuals from fourmultiplex pedigrees. All mutations truncate themature protein and therefore should lead to a function-
less receptor, strongly suggesting that haplo-insufﬁciency of PTHR1 is the underlying cause of nonsyndromic PFE. Although complete
inactivation of PTHR1 is known to underlie the autosomal-recessive Blomstrand osteochondrodysplasia (BOCD), a lethal form of short-
limbed dwarﬁsm, our data now imply that dominantly acting PTHR1mutations that lead to haplo-insufﬁciency of the receptor result in
a nonsyndromic phenotype affecting tooth development with high penetrance and variable expressivity.Nonsyndromic primary failure of tooth eruption (PFE) is
a rare condition that has high penetrance and variable
expressivity and in which tooth retention occurs without
evidence of any obviousmechanical interference (Figure S1
in the Supplemental Data available online).1,2 Instead,
malfunction of the eruptive mechanism itself appears
to cause nonankylosed permanent teeth to fail to erupt,
although the eruption pathway has been cleared by
bone resorption. Teeth in the posterior quadrants of the
upper and lower jaw are preferentially affected, and this
usually results in a progressive open bite extending from
anterior to posterior (Figure 1A). Nonankylosed teeth
tend to become ankylosed, i.e., the root directly fuses to
the jawbone when mechanical forces are applied, render-
ing orthodontic treatment of affected teeth generally
unsuccessful.
We have identiﬁed four families, each with at least two
members affected by nonsyndromic PFE in successive gen-
erations, strongly suggesting dominant transmission of
the underlying defect (Figure 1B and Table 1). The patients
were referred to the Department of Orthodontics at the
University of Wuerzburg Dental Clinic by local dentists,
orthodontists, and oral surgeons because of eruption
disturbances in permanent teeth. All subjects considered
themselves to be in good health and had no history of
any relevant medical condition, dental trauma, inﬂamma-
tion of the relevant alveolar area, or congenital anomalies
such as cleft lip and palate or craniofacial malformations.
In addition, index patients of family ZD1 (III:2) and ZD3
(II:1) were carefully examined in the course of a genetic-
counseling session by one of the authors (B.S.F). PhysicalThe Americaexamination of both patients did not reveal any excep-
tional skeletal deformation or enchondromatosis. Medical
history suggested neither hypo- nor hyperparathyroidism.
Patient III:2 (height 1.86 m, age 27) underwent surgery of
unilateral club foot at the age of one year. Patient II:1
(height 1.89 m, age 23) exhibited a leptosomic body stat-
ure and a minimal pectus carinatum. The study followed
the tenets of the Declaration of Helsinki and was approved
by the local ethics committee of the University of Wuerz-
burg (study ID 103/04). Blood samples for genetic analysis
were taken only after each patient received a detailed
explanation of the nature and possible consequences of
the study and granted informed consent.
A standardized assessment, including clinical and radio-
graphic examinations, of the dental condition of all
patients was performed. In general, a dental panoramic
tomography was available. In accordance with Profﬁt and
Vig1, characteristic features of primary failure of eruption
included (1) posterior more than anterior tooth involve-
ment, (2) varying degrees of abnormalities presenting dis-
tally to the ﬁrst tooth involved, (3) eruption of involved
teeth all the way into occlusion followed by cessation to
erupt; or failure to erupt even though the overlying bone
was removed by apparently normal resorption to provide
an eruption pathway, and (4) no response of involved
teeth to orthodontic forces. All characteristics (1) to (4)
were present in 13 of the 15 patients. No patient who
had undergone orthodontic treatment saw any improve-
ment. In the remaining two patients (ZD2-I:2; ZD3-I:1,
see Table 1), affected teeth had probably been removed
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D E
B Figure 1. PTHR1 Mutations in Individ-
uals Affected by Nonsyndromic PFE and
Their Effect on Transcript Splicing
(A) Eruption failure of posterior teeth and
deficits in alveolar bone growth result in
a severe bilateral open bite. Shown are
an intraoral view (upper chart) and ortho-
pantomogram (lower chart) of patient
ZD1-III:2.
(B) Pedigree drawings showing individuals
examined clinically and by mutation anal-
ysis. PTHR1 mutations segregating with
the clinical phenotype are presented in
brackets.
(C) RT-PCR analysis of splice-site mutation
c.1050-3C > G in gingival RNA of patient
ZD1-III:3. Sequence traces of the normal
allele and the shortened mutant allele
demonstrate the excision of exon 12 in
the mature transcript of the mutated
allele.
(D) In vitro minigene reporter analysis
of splice-acceptor sequence mutation
c.1050-3C > G. Irregular transcript splic-
ing is observed for the mutant allele such
that the entire PTHR1 exon 12 is skipped.
(E) In vitro minigene reporter analysis of
splice-donor sequence mutation c.543þ
1G > A. Irregular transcript splicing
involving a vector-specific cryptic splice
is observed for the mutant allele.In one of the multiplex families (ZD1, see Figure 1B),
DNA samples of eight affected and four unaffected mem-
bers were genotyped wih the Affymetrix Human Mapping
250K StyI array and were used for analysis aimed at estab-
lishing chromosomal linkage to disease. For each individ-
ual, an aliquot of 250 ng genomic DNA was digested
with StyI, an adaptor was ligated, and molecules were am-
pliﬁed by PCR, puriﬁed, fragmented, and labeled with bio-
tin. The cocktail was then hybridized to the StyI array,
which contains roughly 238,000 SNPs. Genotype calling
was performed with Affymetrix software GTYPE v4.1.
The QC call rate performed with the Dynamic Model algo-
rithm (DM) was above the 93% DM call-rate threshold for
all samples, and samples were further analyzed with the
Bayesian Robust Linear Model including the Mahalanobis
distance classiﬁer (BRLMM).3 For ﬁnal data analysis, only
genotypes with a BRLMM conﬁdence threshold of less
than 0.3 were included.
Quality control and data conversion were managed by
ALOHOMORA.4 The correct relationship of individuals
within the families was checked with the software Graph-
ical Representation of Relationships (GRR).5 For GRR, we
selected 14,339 SNPs, distributed on the autosomes, with
aminimal distance of 200 kbp betweenmarkers and amin-
imal minor allele frequency of 0.1 in Europeans. For each
pair of individuals, GRR calculates over the 14,339 markers782 The American Journal of Human Genetics 83, 781–786, Decembthe Identical-by-State (IBS) mean and standard deviation.
The graphical plot of IBS mean versus IBS standard devia-
tion facilitates distinguishing between parents and off-
spring, siblings, half siblings, and cousins, as well as iden-
tical or unrelated individuals. SNPs with Mendelian errors
were detected by PedCheck6, and genotypes were deleted
in all individuals; unlikely genotypes (double recombi-
nants), identiﬁed with Merlin,7 were deleted in the indi-
viduals where they appeared. For parametric multipoint
LOD score analysis and haplotyping, Merlin was used
with complete penetrance and a trait locus allele frequency
of 0.001. Marker allele frequencies for a European popula-
tion as well as genetic positions were extracted from the
Affymetrix SNP annotation ﬁle (version na21). From
238,304 SNPs on the array, 238,230 had a physical and ge-
netic position. To reduce the impact of Linkage Disequilib-
rium (LD) between closely linked markers on the LOD
score analysis, we recalculated the pedigree with smaller
sets of markers (136,390 and 82,918 SNPs, respectively)
such that there was a minimal distance of 1,000 and
10,000 bp between neighboring markers.
Parametric linkage analysis with a dominant model re-
vealed two regions with a maximal LOD score of 2.41,
a 31.8 Mbp interval between ﬂanking markers rs1402366
and rs13074914on chromosome 3p14.3-p24.3, and an
8.0 Mbp interval ﬂanked by markers rs1328369 ander 12, 2008
Table 1. Characterization of Family Members with PTHR1 Mutations
Family
ID
Pedigree
Positionc
Height
(m)d Nucleotide Change Amino Acid Change
Affected Teetha
Upper Rightb Upper Leftb Lower Leftb Lower Rightb
8 7 6 5 4 8 7 6 5 4 8 7 6 5 4 8 7 6 5 4
ZD1 I:1 1.70 c.1050-3C > G p.Cys351SerfsX133 $ $ $ $ $ - - $ $ $ $ $ $ $ $ 3 - - $ $
II:1 1.82 c.1050-3C > G p.Cys351SerfsX133 - - - - - - - - - $ - - - $ - - - - - -
II:2 n.a. no no
II:3 n.a. no no
II:4 1.65 c.1050-3C > G p.Cys351SerfsX133 - - 3 $ $ - - 3 - - - - 3 3 - - 3 - $ $
II:5 n.a. no no
II:6 1.62 c.1050-3C > G p.Cys351SerfsX133 3 - - $ $ $ $ $ $ $ $ $ $ $ $ 3 - 3 $ $
III:1 1.70 c.1050-3C > G p.Cys351SerfsX133 - - - - - - - - - $ - - - - $ - - - - $
III:2 1.88 c.1050-3C > G p.Cys351SerfsX133 - - - - - - - - - - - - - - - - - - - -
III:3 1.72 c.1050-3C > G p.Cys351SerfsX133 $ $ $ $ $ $ $ $ $ $ - - - - $ $ $ $ $ $
III:4 1.70 c.1050-3C > G p.Cys351SerfsX133 - - - - - - - - - - - - - - - $ $ $ $ $
III:5 n.a. no no
ZD2 I:1 1.82 no no
I:2 1.78 c.543þ1G > A p.Glu182ValfsX20 3 3 $ $ $ 3 3 $ $ $ 3 3 3 $ $ $ $ $ $ 3
II:1 1.96 c.543þ1G > A p.Glu182ValfsX20 - - - - $ - - - - - $ $ $ $ $ $ $ $ $ $
II:2 1.93 c.543þ1G > A p.Glu182ValfsX20 $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - $
II:3 1.75 no no
ZD3 I:1 1.70 c.1050-3C > G p.Cys351SerfsX133 3 3 $ $ $ $ $ $ 3 $ 3 3 3 $ $ $ $ 3 $ 3
II:1 1.89 c.1050-3C > G p.Cys351SerfsX133 - - - - - - - - - - - - - $ $ - - - $ $
ZD11 I:1 1.86 c.463G > T p.Glu155Ter $ $ 3 $ $ - - - - $ $ $ 3 3 $ - - - $ $
II:1 1.80 c.463G > T p.Glu155Ter - - - - - - - - - - - - - - $ - - - - $
II:2 n.a. no no
a Tooth present ($), not present (3), or affected (-). No entry means there was no information.
b 4 ¼ first premolar; 5 ¼ second premolar; 6 ¼ first molar; 7 ¼ second molar; and 8 ¼ third molar.
c See Figure 1.
d n.a. ¼ not available.rs7988100 on chromosome 13q31.3-q33.1 (Figures S2–S4).
The latter region includes 31 known protein-coding genes
as deﬁned by the NCBI mRNA reference sequences collec-
tion (RefSeq) presently totaling 445 exons (Table S1). Of
these, 423 coding exons and their respective adjacent
splice acceptor and donor sites were analyzed by direct
sequencing of patients ZD1-II:4 and ZD1-III:3, as well as
individual ZD1-II:3 as an unaffected control. No disease-
associated mutation could be detected, thus effectively
excluding 13q31.3-q33.1 as a PFE candidate region.
The second interval of interest on 3p harbors 301 RefSeq
genes (Table S2 ), making a systematic exon-sequencing
strategy unfeasible. We therefore selected candidates
from the chromosomal region on the basis of a number
of criteria, such as expression in bone or bone-associated
tissue, functional considerations of the encoded protein,
and a known role in disease processes or animal models
of disease. Under this approach, one of the candidates
encoding the parathyroid hormone receptor 1 (PTHR1
[MIM 168468]) appeared to be a good positional candidate
for PFE for several reasons. PTHR1 is a member of the
G protein-coupled receptor family class B (secretin-like)
and binds parathyroid hormone (PTH [MIM 168450])
and parathyroid hormone-like hormone (PTHLH [MIM
168470]) with equal afﬁnity.8 In tooth development,
PTHLH expression is restricted to the epithelial layer,
whereas PTHR1 expression is found in both the adjacentThe Americandental mesenchyme and in the alveolar bone.9,10 In addi-
tion, gene-manipulated mice deﬁcient for either PTHR1 or
PTHLH die perinatally,11,12 but transgenic rescue of the
PTHLH knockout mice by either chondrocyte-targeted ex-
pression of PTHLH9 or constitutive expression of PTHR113
results in viable animals with dysmorphic features, includ-
ing failure of tooth eruption. This stronglypoints to a roleof
PTHLH and/or PTHR1 signaling in the regulation of epithe-
lial-mesenchymal interactions during the development of
epithelial organs such as teeth. Finally, Blomstrand osteo-
chondrodysplasia (BOCD), a lethal form of short-limbed
dwarﬁsm, has long been known to be associatedwith reces-
sive, loss-of-functionmutations in the PTHR1 gene.14–19 In
addition to skeletal anomalies, the clinical features ofBOCD
were recently reevaluated and shown to include severe
abnormalities in tooth morphogenesis.20 In two affected
fetuses, deciduous teethwere present but severely impacted
within the surrounding alveolar bone, leading to distor-
tions in their architecture and orientation.
Consequently, we analyzed all 14 PTHR1 coding exons
and the respective intron-exon boundaries by direct
sequencing (Table S3) and identiﬁed three novel heterozy-
gous mutations in each of the four multiplex pedigrees
(Figure 1B and Table 1). Affected individuals, but not those
without pathological ﬁndings, harbored the splice junc-
tion mutation c.1050-3C > G (families ZD1 and ZD3) or
c.543þ1G > A (family ZD2) or the nonsense mutationJournal of Human Genetics 83, 781–786, December 12, 2008 783
c.463G > T (family ZD11) (Figure 1B). The latter change
directly results in a termination codon and truncates the
PTHR1 protein at amino acid position 155 (p.Glu155Ter).
Haplotyping at the PTHR1 locus revealed that mutation
c.1050-3C > G originates from a common founder in fam-
ilies ZD1 and ZD3, and all affected individuals share an
extended haplotype (Figure S5). Mutations c.543þ1G > A
and c.463G > T were analyzed in 178 control individuals
of German descent21 by PCR ampliﬁcation with primer
pair PTHR1-RNA-ex6F (50-GGA ATG GGA CCA CAT CCT
GT-30) and BamHI-PTHR1-ex7R (50-CGC GGA TCC TGG
GGT GGG AGT GAA TTT AT-30) and subsequent direct
sequencing with primer PTHR1-RNA-ex6F. The c.1050-
3C > Gmutation in PTHR1 exon 12 was ampliﬁed by PCR
in the same 178 controls with primer pair PTHR1-ex12F
(Table S3) and PTHR1-ex12R2 (50-CAG AGA TGC AGT
GAC AGA GC-30) and tested for the presence of the nucle-
otide change by restriction enzyme digestion with BstNI.
None of the three mutations identiﬁed in our PFE patients
was found in the 178 controls (356 alleles), formally ex-
cluding the possibility that one of these changes represents
a rare polymorphic variant in the general population.
The functional effect of splice junctionmutation c.1050-
3C > G on transcript splicing was further analyzed in gin-
gival RNA from patient ZD1-III:3 (Figures 1B and 1C). Total
RNA was isolated, and ﬁrst-strand complementary DNA
was generated from total RNA by reverse transcription
(RT). This DNA served as a template in subsequent RT-
PCR reactions. PCR products were generated with exonic
primers PTHR1-RNA-ex10F (50-GAA GTA CCT GTG GGG
CTT CA-30) and PTHR1-RNA-ex15R (50-TCG CCA TTG
CAG AAA CAG TA-30). After agarose gel excision and puri-
ﬁcation, PCR products were cycle sequenced. Compared to
a control transcript, the mutant allele results in a complete
exclusion of exon 12, thus fusing PTHR1 exon 11 to exon
13 (Figure 1C). This should cause a frame shift at codon
351 and thus create a new reading frame that encodes an
additional, PTHR1-unrelated 133 C-terminal amino acid
(p.Cys351SerfsX133). The skipping of the entire exon
12 as a result of the c.1050-3C > G mutation was further
conﬁrmed in an in vitro minigene reporter assay that is
based on COS7 cell expression of normal and mutant al-
leles in the context of ﬂanking reporter exons (Figure 1D).
Because gingival tissue was unavailable from affected
members of family ZD2, PTHR1 mutation c.543þ1G > A
was analyzed via the minigene reporter assay. The region
encompassing the affected splice site and the adjacent
exon(s) was ampliﬁed from the patient’s genomic DNA
by PCR with oligonucleotide primer pairs EcoRI-PTHR1-
ex7F (50-CCG GAA TTC TTG GAG CTA GGG GTT CAG
TG-30) and BamHI-PTHR1-ex7R. Coupling EcoRI and
BamHI recognition sequences to the forward and reverse
primers, respectively, ensured directional insertion into
the pSPL3b vector (GIBCO, Life Technology, Eggenstein,
Germany). Wild-type and mutant clones were selected
for transformation into COS7 cells. After 24 hr, mRNA
was isolated from the COS7 cells and analyzed by RT-PCR784 The American Journal of Human Genetics 83, 781–786, Decembwith exonic primer PTHR1-RNA-ex7F (50-GCC TGG GCA
CAA CAG GAC-30) and vector primer SA2 (50-ATC TCA
GTG GTA TTT GTG AGC-30). The RT-PCR products were
sequenced and demonstrated the loss of the donor
splice site of entire exon 7 (Figure 1E), thus predicting a
frame shift and a premature termination of the protein
(p.Glu182ValfsX20).
Mutations in the PTHR1 gene have been associated with
a number of clinically distinct skeletal disorders. Complete
or almost complete inactivation of both PTHR1 alleles is
associated with autosomal-recessive BOCD, a skeletal dys-
plasia with advancement of bone maturation.14–20 In con-
trast, autosomal-dominant gain-of-function mutations in
PTHR1 lead to short-limb dwarﬁsm, known as Jansen
metaphyseal chondrodysplasia, and characterized by a
retarded differentiation of chondrocytes.22 Clinically, this
phenotype can be confused with hyperparathyroidism.
Another condition called enchondromatosis, or Ollier
disease, which can manifest as multiple cartilage tumors
and is frequently associated with skeletal deformity, can
be caused by autosomal-dominant missense mutations
in the PTHR1 gene.23 Finally, Eiken syndrome, a rare
autosomal-recessive skeletal dysplasia, is characterized by
multiple epiphyseal dysplasia and extremely retarded ossi-
ﬁcation and differs from Jansen and Blomstrand chondro-
dysplasia and from enchondromatosis.18 The autosomal-
dominant PTHR1 mutations identiﬁed in our families
with nonsyndromic PFE truncate the mature receptor
protein before the ﬁrst transmembrane domain (TM)
(p.Glu182ValfsX20; p.Glu155Ter) or eliminate the ﬁfth,
sixth, and seventh TM, the connecting intracellular and
extracellular loops, and the cytoplasmic tail (p.Cys-
351SerfsX133). In all cases, the mutations should lead to
premature proteolytic degradation of the precursor protein
or to a functionless receptor, thus suggesting that haploin-
sufﬁciency of PTHR1 is likely to be the underlying princi-
ple of nonsyndromic PFE. Interestingly, PFE has not been
reported as a symptom in heterozygous carriers of autoso-
mal-recessive BOCD.14–20 This may, however, be explained
by an incomplete medical history of the carrier parents of
BOCD fetuses. PFE is now the ﬁfth disease associated with
mutations in the PTHR1 gene further highlighting the fact
that this receptor has multiple functional aspects that can
be disrupted by mutations acting in deﬁned and speciﬁc
modes leading to the various associated diseases. A simi-
larly complex pattern of genotype-phenotype correlation
was shown in other skeletal disorders, such as the FGFR-
associated craniosynostosis.24
In both BOCD patients20 and rescued PTHLH-transgenic
PTHLH knockout mice9, tooth buds appear to develop nor-
mally, and it appears that there is regular secretion and
maturation of dentine and enamel during the crown stage
of tooth development. It is only later that progressive dis-
tortion of teeth and failure to erupt become evident, indi-
cating that subtle disturbances in alveolar bone resorption
may prevent the formation of an eruption pathway. By the
time an eruption pathway forms, the alveolar bone surfaceer 12, 2008
is mainly covered by osteoclasts (bone resorption), whereas
osteoblasts (bone formation) are virtually absent.25 Be-
cause nonsyndromic PFE patients do not show any signs
of peripheral skeleton abnormalities, a systemic impair-
ment of osteoclast formation or function as a result of
PTHR1 haploinsufﬁciency appears unlikely. Rather, non-
syndromic PFE might be attributable to a threshold-depen-
dent disturbance in crosstalk between mesenchymal and
epithelial cells in the immediate vicinity of the eruption
pathway, and this disturbance might impair the delicate
balance of bone resorption and formation. Because osteo-
clasts do not appear to express functional PTHR1 receptors
at their cell surfaces,26,27 paracrine or juxtacrine signaling
mediated by PTHR1 receptor-positive cells, e.g., in the
dental follicular mesenchyme, needs to be considered.
Supplemental Data
Five ﬁgures and three tables are available with this article online at
http://www.ajhg.org/.
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